Detalhe da pesquisa
1.
HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapy.
J Med Virol
; 88(12): 2115-2124, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27197719
2.
Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patients.
HIV Clin Trials
; 15(4): 176-83, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25143026
3.
Potential anti-inflammatory effects of maraviroc in HIV-positive patients: a pilot study of inflammation, endothelial dysfunction, and coagulation markers.
Scand J Infect Dis
; 46(6): 466-70, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24738757
4.
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection.
J Antimicrob Chemother
; 68(1): 193-9, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22984206
5.
Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimens.
Ther Drug Monit
; 35(6): 785-90, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24061444
6.
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.
J Antimicrob Chemother
; 67(6): 1479-85, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22361986
7.
HIV-2 infection, end-stage renal disease and protease inhibitor intolerance: which salvage regimen?
Clin Drug Investig
; 31(5): 345-9, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21344955
8.
Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration.
Ann Pharmacother
; 44(5): 838-43, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20371753
9.
Modifications of residual viraemia in human immunodeficiency virus-1-infected subjects undergoing repeated highly active antiretroviral therapy interruptions.
J Med Microbiol
; 58(Pt 1): 121-124, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19074663
10.
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
PLoS One
; 13(1): e0190803, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29293676
11.
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
PLoS One
; 12(2): e0172159, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28245248
12.
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.
PLoS One
; 12(10): e0185728, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28977040
13.
Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens.
AIDS Res Hum Retroviruses
; 31(1): 71-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25092266
14.
No evidence of autoimmune disorders in antiretroviral-experienced HIV-1-infected individuals after long-term treatment with raltegravir.
Antivir Ther
; 18(3): 321-7, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23047152
15.
Maternal HIV status and infant feeding practices among Ugandan women.
SAHARA J
; 7(1): 24-9, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21409292
16.
Nonnucleoside reverse transcriptase inhibitor concentrations during treatment interruptions and the emergence of resistance: a substudy of the ISS-PART Trial.
AIDS Res Hum Retroviruses
; 26(5): 541-5, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20455761
17.
Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA.
J Clin Virol
; 46(4): 367-70, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19782638
18.
Immediate versus delayed surgical intervention for reconstructive therapy of HIV-associated facial lipoatrophy: a randomized open-label study.
AIDS Res Hum Retroviruses
; 25(10): 979-87, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19795984
19.
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) study.
J Acquir Immune Defic Syndr
; 46(1): 39-47, 2007 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17972364